World

China’s NMPA Accepts Clinical Trial Application for Harbour BioMed’s Obesity Antibody LET003

Harbour BioMed (the "Company"; HKEX: 02142), a global biopharmaceutical company committed to the discovery and development of novel antibody therapeut...

 November 20, 2026 | News

Thermo Fisher Scientific Introduces Gibco VaxEvo CD 293 Medium for Adenovirus Vaccine Production

Thermo Fisher Scientific, the world leader in serving science, announced the Gibco™ VaxEvo™ CD 293 Medium, a chemically defined and animal orig...

 November 19, 2026 | News

Lonza Licenses NeuroPortal Blood-Brain Barrier Technology to China Medical System

Lonza grants CMS global rights to newly acquired TfR1 technology in up to two neurodegenerative disease targets.  Lonza’s NeuroPortal...

 November 18, 2026 | News

2026 Drug Approvals: How the FDA, China, Japan and Europe Compare

For most of the last two decades, a year in drug approvals could be summarised in a single number: how many new molecular entities the US Food and Drug Adm...

 November 17, 2026 | Analysis

IDEAYA Nominates IDE101 as Development Candidate for CDKN2A-Deficient Solid Tumours

Development candidate demonstrates encouraging preclinical activity in CDKN2A-deficienct tumor models as a monotherapy and in combi...

 November 17, 2026 | News

Biomatter Raises $18 Million to Accelerate AI-Designed Enzymes From Lab to Market

AstraZeneca, BASF, and Sanofi among 25+ enterprise customers, with more than 50 custom enzymes delivered Proceeds will grow the commercial team and US p...

 November 13, 2026 | News

Pfizer Secures Up to $1.5 Billion From Blackstone to Advance Monthly GLP-1 Programme

Blackstone to provide Pfizer up to $1.5 billion through 2028 to support clinical program for GLP-1 receptor agonist Pfizer Inc. (NYSE: PFE) and Blackstone...

 November 13, 2026 | News

IASO Bio Secures China IND Approval for In Vivo CAR-T Therapy IASO208

First lentiviral-vector-based in vivo CAR-T product from China to receive a U.S. FDA IND clearance; a Phase Ib study in R/R B-NHL will be initiated directl...

 November 12, 2026 | News

FDA Approves Promega OncoMate MSI Dx System to Guide KEYTRUDA Treatment

The U.S. Food and Drug Administration (FDA) has approved the Promega OncoMate MSI Dx Analysis System designed to identify patients with solid tumors with h...

 November 12, 2026 | News

Pierre Fabre and XtalPi Partner on AI-Driven Oncology Drug Discovery

Laboratoires Pierre Fabre and XtalPi (XtalPi Holdings Limited, 2228.HK) are pleased to announce an agreement under which they will collaborate on the disco...

 November 11, 2026 | News

Sanyou Bio Secures Nearly RMB 100 Million in Series C to Advance AI-Driven Drug R&D

Accelerating the Development of an AI-Driven Ecosystem for Innovative Drug R&D and Translation Sanyou Biopharmaceuticals Co., Ltd. ("Sanyou Bio") rece...

 November 11, 2026 | News

DeciBio Launches Precision Medicine Market Intelligence Portal with AI Assistant DeciChat

DeciChat synthesizes thousands of data points across primary data sources to deliver deep insights into precision medicine markets instantly. De...

 November 10, 2026 | News

KaliVir’s VET3-TGI Regimens Show 71% Response Rate in Advanced Skin Cancers in Early Trial

Preliminary data from intratumoral VET3-TGI presented in oral session at SITC 2026; abstract recognized among SITC’s top 150 abstracts Responses o...

 November 10, 2026 | News

Vir Biotechnology’s Hepatitis Delta Combo Suppresses Virus to Undetectable Levels in All 28 Week 96 Completers

Data presented at AASLD The Liver Meeting demonstrated 100% of participants (28/28) who completed Week 96 of combination therapy reached undetectable v...

 November 10, 2026 | News


News

Stay Connected

Sign up to our free newsletter and get the latest news sent direct to your inbox

Show

Forgot your password?

Show

Show

Lost your password? Please enter your email address. You will receive a link to create a new password.

Back to log-in

Close